Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 13
2003 12
2004 9
2005 12
2006 17
2007 21
2008 24
2009 16
2010 19
2011 32
2012 43
2013 58
2014 62
2015 77
2016 88
2017 79
2018 104
2019 129
2020 154
2021 193
2022 231
2023 199
2024 241
2025 325
2026 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,974 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
Planchard D, Jänne PA, Cheng Y, Yang JC, Yanagitani N, Kim SW, Sugawara S, Yu Y, Fan Y, Geater SL, Laktionov K, Lee CK, Valdiviezo N, Ahmed S, Maurel JM, Andrasina I, Goldman J, Ghiorghiu D, Rukazenkov Y, Todd A, Kobayashi K; FLAURA2 Investigators. Planchard D, et al. N Engl J Med. 2023 Nov 23;389(21):1935-1948. doi: 10.1056/NEJMoa2306434. Epub 2023 Nov 8. N Engl J Med. 2023. PMID: 37937763 Clinical Trial.
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial.
Cheng Y, Zhang W, Wu L, Zhou C, Wang D, Xia B, Bi M, Fu X, Li C, Lv D, Zhao Y, Chen G, Yi T, Huang J, Li M, Yang R, Huang X, Wang Y, Zhang M, Pan Y, Sun Y, Hu S, Zhang X, Zhou M, Fang J, Jin F, Liu Y, Li Y, Zhang Z, Hu J, Liu L, Wang R, Li Y, Gu K, Ding C, Fan Q, Zhang G, Chen Y, Jiang L, Zheng WE, Chen S, Huang C, Han Z, Yang H, Wang J, Wang B, Wu H, Bao Y, Li M, Luo X, Gu S, Yu W, Xu K, Zhang S, Yu J. Cheng Y, et al. Among authors: hu j. JAMA Oncol. 2025 Jan 1;11(1):16-25. doi: 10.1001/jamaoncol.2024.5019. JAMA Oncol. 2025. PMID: 39541202 Free PMC article. Clinical Trial.
Expert consensus on cancer treatment-related lung injury.
Lin X, Guo H, Zhao W, Li M, Lin G, Chu Q, Chen E, Chen L, Chen R, Chu T, Deng H, Deng Y, Dong H, Dong W, Dong Y, Fang W, Gan X, Gong L, Gu Y, Han Q, Hao Y, He Y, Hu C, Hu J, Hu Y, Jiang Y, Jin Y, Lan F, Li W, Li W, Liang W, Liu A, Liu D, Liu M, Liu M, Liu Z, Liu Z, Luo Q, Miao L, Mu C, Pan P, Peng P, Qin J, Qin Y, Shen P, Shi M, Song Y, Su C, Su J, Su X, Tan X, Tang K, Tang X, Tian P, Wang B, Wang H, Wang K, Wang M, Wang Q, Wang W, Wang Z, Wu D, Xu F, Xu Y, Xu C, Xie Z, Xie X, Yang B, Yang M, Ye F, Ye X, Yu Z, Zhang J, Zhang J, Zhang X, Zhao F, Zheng X, Zhu B, Zhu Z, Zhou J, Zhou J, Zhou M, Zhou Q, Zou Z, Kidane B, Bignami E, Sakamaki F, Roviello G, Taniguchi H, Jeon K, Saric L, Ariza-Prota M, La-Beck NM, Kanaji N, Watanabe S, Shukuya T, Akaba T, Leong TL, Gesierich W, Koga Y, Tanino Y, Uehara Y, Li S, Chen R, Zhou C. Lin X, et al. Among authors: hu j. J Thorac Dis. 2025 Apr 30;17(4):1844-1875. doi: 10.21037/jtd-2025-292. Epub 2025 Apr 28. J Thorac Dis. 2025. PMID: 40400937 Free PMC article. Review.
Central nervous system efficacy of aumolertinib versus gefitinib in patients with untreated, EGFR-mutated, advanced non-small cell lung cancer: data from a randomized phase III trial (AENEAS).
Lu S, Dong X, Jian H, Chen J, Chen G, Sun Y, Ji Y, Wang Z, Shi J, Lu J, Chen S, Lv D, Zhang G, Liu C, Li J, Yu X, Lin Z, Yu Z, Wang Z, Cui J, Xu X, Fang J, Feng J, Xu Z, Ma R, Hu J, Yang N, Zhou X, Wu X, Hu C, Zhang Z, Lu Y, Hu Y, Jiang L, Wang Q, Guo R, Zhou J, Li B, Hu C, Tong W, Zhang H, Ma L, Chen Y, Jie Z, Yao Y, Zhang L, Weng J, Li W, Xiong J, Ye X, Duan J, Yang H, Sun M, Wei H, Wei J, Zhang Z, Wu Q. Lu S, et al. Among authors: hu j. Cancer Commun (Lond). 2024 Sep;44(9):1005-1017. doi: 10.1002/cac2.12594. Epub 2024 Jul 17. Cancer Commun (Lond). 2024. PMID: 39016053 Free PMC article. Clinical Trial.
Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study.
Yang JJ, Zhang Y, Wu L, Hu J, Wang ZH, Chen JH, Fan Y, Lin G, Wang QM, Yao Y, Zhao J, Chen Y, Fang J, Song Y, Zhang W, Cheng Y, Guo RH, Li XY, Shi HP, Xue WZ, Han D, Zhang PL, Wu YL. Yang JJ, et al. Among authors: hu j. J Clin Oncol. 2024 Nov;42(31):3680-3691. doi: 10.1200/JCO.23.02363. Epub 2024 Jul 26. J Clin Oncol. 2024. PMID: 39058972 Free PMC article. Clinical Trial.
1,974 results